ScholarWorks@UA

Development of acetylcholine-binding protein (AChBP) as a biosensor for serotonin ligands

DSpace/Manakin Repository

Show simple item record

dc.contributor.author Ataian, Yeganeh
dc.date.accessioned 2018-06-13T23:34:26Z
dc.date.available 2018-06-13T23:34:26Z
dc.date.issued 2018-05
dc.identifier.uri http://hdl.handle.net/11122/8644
dc.description Thesis (Ph.D.) University of Alaska Fairbanks, 2018 en_US
dc.description.abstract Acetylcholine-binding protein (AChBP) is a water-soluble novel protein with a high sequence similarity (15-30% identity) to ligand-gated ion channel (LGIC) receptors. The crystal structure of AChBP is used to study the extracellular domain of the pentameric LGICs such as nicotinic acetylcholine receptors (nAChRs) and 5-hydroxytryptamine type 3 receptors (5-HT₃Rs); and homology models have been developed to study receptor-ligand interactions. The 5-HT₃ serotonin receptors are potential therapeutic targets for multiple nervous system disorders such as alcohol and drug dependence, anxiety, depression, schizophrenia, sleep, cognition, memory, and chemotherapy-induced and post-operative nausea and vomiting. Therefore, the ligands that target the 5-HT₃Rs are considered powerful therapeutic agents. As such, 5-HT₃ serotonin receptors have been the targets of drug discovery efforts. The main objective of the current protein engineering project was to develop a soluble serotonin-binding protein using AChBP, which would mimic the specificity of the native 5-HT₃ serotonin receptor. Once developed, this soluble protein would be used as a model to design an array of receptors, which could be placed on biosensors for high-throughput drug screening (HTDS). The results of site-directed mutagenesis of AChBP demonstrated that mutation of certain AChBP residues to its equivalent in serotonin resulted in an increased affinity of AChBP for serotonin ligands, and that each individual mutation increased the affinity of AChBP to a certain degree. It indicates that this approach is going in the right direction but multiple mutations will probably be needed to get to an AChBP whose affinity is equivalent to wild-type serotonin. In addition, the most significant changes appeared to be in the C-loop as it produced the largest increase in affinity of AChBP for serotonin agonists. The results also support the proposed C-loop closure model for the receptor, and based on data presented here, a new alignment of the C-loop is suggested. en_US
dc.language.iso en_US en_US
dc.subject Acetylcholine en_US
dc.subject Receptors en_US
dc.subject Serotonin en_US
dc.subject Agonists en_US
dc.subject Antagonists en_US
dc.subject Ligand binding (Biochemistry) en_US
dc.subject Receptor-ligand complexes en_US
dc.title Development of acetylcholine-binding protein (AChBP) as a biosensor for serotonin ligands en_US
dc.type Thesis en_US
dc.type.degree phd en_US
dc.identifier.department Department of Chemistry and Biochemistry en_US
dc.contributor.chair Schulte, Marvin
dc.contributor.chair Duffy, Lawrence
dc.contributor.committee Kuhn, Thomas
dc.contributor.committee Bult-Ito, Abel


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search ScholarWorks@UA


Advanced Search

Browse

My Account

Statistics